Actively Recruiting
SARS Cov 2 Vaccination in Adolescents With Juvenile Idiopathic Arthritis
Led by Nantes University Hospital · Updated on 2024-06-21
200
Participants Needed
1
Research Sites
55 weeks
Total Duration
On this page
Sponsors
N
Nantes University Hospital
Lead Sponsor
U
University Hospital, Angers
Collaborating Sponsor
AI-Summary
What this Trial Is About
Since june 2021, vaccination against the SARS-Cov2 virus is recommanded in France to all children from 12 to 18 years old. In the specific population of teenagers living with juvenile arthritis, the vaccine seems to be safe and well tolerated. It has been shown previously that this population has a vaccine coverage lower than the global population even though few datas are available on this topic The aim of this resarch is to study the vaccination coverage against the SARS-Cov2 virus and more specifically the reasons why adolescents were or were not vaccinated in the population of adolescents with juvenile arthitis followed up in Angers, Nantes and Rennes. For this purpose, a review of the medical record will be done and a questionnaire will be adressed to the family of patients in order to collect informations about the disease, the treatments, the motives or obstacles to vaccination. Secondaries end points are safety of the vaccination, consequences on the juvenile arthritis (such as changes in the medication, flare-up of the illness) and the occurence of covid infection after vaccination.
CONDITIONS
Official Title
SARS Cov 2 Vaccination in Adolescents With Juvenile Idiopathic Arthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients from 12 to 18 years old, on January the 1st 2022
- Patients followed up from juvenile arthritis
- Patients followed up in 2021 and 2022
You will not qualify if you...
- Patients under 12 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Nantes
Nantes, Loire-Atlantique, France, 44300
Actively Recruiting
Research Team
S
Soizic TIRIAU, Dr
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here